Genetically, the progeny from the female chimera are sons and daughters of Father #1 and Father #2 (horizontal line). matings between males and females result in the fertilization of oocytes by spermatozoa and the generation of progeny that inherit alleles from both parents. In mammals, experimentally generated embryos with alleles only processed through oogenesis or only Edicotinib processed through spermatogenesis usually die during development because of imbalances in imprinted gene expression [14]. Thus, epigenetic differences derived during male and female gametogenesis are required for normal mouse development. Interestingly, viable bimaternal female mice have been generated by nuclear transfer into oocytes [4]. This required the introduction of nuclei fromH19mutant nongrowing oocytes into wild-type fully produced oocytes. The frequency of obtaining viable mice from these reconstructed oocytes with genetic information derived from two mothers was <1%. However, if the donor nucleus from your nongrowing oocyte transporting theH19mutation also Edicotinib experienced a deletion of theDlk1-Dio3intergenic region, then there Mouse monoclonal to PROZ was a high success rate in obtaining bimaternal female mice from your reconstructed oocytes [5]. The producing bimaternal mice were relatively normal but weighed less than controls, and there were some gene expression differences. These bimaternal mice also experienced significantly longer life spans compared to controls [6]. Viable progeny with two fathers have yet to be generated. To generate progeny with alleles derived from two males, the cells from one male must undergo meiosis to produce oocytes. This is possible in cases of XY sex-reversal. XY sex-reversed individuals are genetically male but develop as females with variable gonadal phenotypes, from dysgenesis to functional ovaries [79]. There are also cases of XY sex-reversal in mice with Edicotinib a Y chromosome ingressed from one genetic background into a different genetic background [10,11]. XY sex-reversed females are capable of initiating oogenesis and in some cases generate functional oocytes [8,9,12]. Thus, two genetic males can generate viable progeny if one is sex-reversed and fertile. In the MRL/MpJ mouse strain, rare XY Edicotinib testicular germ cells of phenotypic males can differentiate into oocytes in spermatogenically active seminiferous tubules although they do not persist in the adult [13]. It has not been decided if these testicular oocytes can be fertilized to produce progeny. Are there other ways for phenotypic males to generate oocytes? Pluripotent stem cell lines provide a system to differentiate germ cells. Embryonic stem (ES) cells are capable of differentiating into every cell type of the adult body, including oocytes and sperm. Although this has only been exhibited for mouse and rat, it seems likely that ES cells from other species (e.g., human) would also have the ability to differentiate into germ cells under the appropriate conditions [1416]. Somatic cells can be reprogrammed using a variety of molecular and chemical reprogramming strategies to generate induced pluripotent stem (iPS) cells [17]. iPS cells have many of the characteristics of ES cells, including pluripotency and the ability to generate germline mouse chimeras [18]. Mouse ES cells that Edicotinib are genetically male spontaneously drop the Y chromosome at a 1%3% frequency, presumably by nondisjunction, resulting in XO subclones [19,20]. In humans, X chromosome monosomy (45,X) usually results in embryo lethality, but in rare cases, viable females are given birth to with Turner syndrome, a variable spectrum of pathologies that includes gonadal dysgenesis and infertility [21]. However, in the mouse, XO individuals develop as viable, fertile females [22,23]. In this study, we exploit XY pluripotent stem cells and in vitro sex reversal to efficiently differentiate functional oocytes in female chimeras. Natural matings of these female chimeras result in the generation of viable male and female mice that combine the haploid genomes from two fathers. Thus, iPS cell technologies.